Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis
Authors
Keywords
-
Journal
LUNG CANCER
Volume 185, Issue -, Pages 107378
Publisher
Elsevier BV
Online
2023-09-15
DOI
10.1016/j.lungcan.2023.107378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review of ancestrality and admixture in Latin America and the caribbean focusing on native American and African descendant populations
- (2023) Thais C. De Oliveira et al. Frontiers in Genetics
- Rare molecular subtypes of lung cancer
- (2023) Guilherme Harada et al. Nature Reviews Clinical Oncology
- Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
- (2023) Diego F. Chamorro et al. Targeted Oncology
- Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
- (2023) Sophie O’Haire et al. Scientific Reports
- The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
- (2022) Albert K. Kwan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- (2022) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Uniting Latin America Through Research: How Regional Research Can Strengthen Local Policies, Networking, and Outcomes for Patients With Lung Cancer
- (2022) Oscar Arrieta et al. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
- Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles
- (2022) Robert Hsu et al. Clinical Lung Cancer
- Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)
- (2022) Andrés F. Cardona et al. Clinical Lung Cancer
- Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
- (2022) Biagio Ricciuti et al. JAMA Oncology
- Real-world ALK Testing Trends in Patients with Advanced Non-small Cell Lung Cancer in the United States
- (2022) Huamao M. Lin et al. Clinical Lung Cancer
- EP16.03-003 Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC)
- (2022) S. Mejia et al. Journal of Thoracic Oncology
- EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil
- (2022) Icaro Alves Pinto et al. ONCOLOGIST
- Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
- (2022) Reem Altaf et al. Frontiers in Oncology
- Risk factors for the development of lung cancer among never smokers: A systematic review
- (2022) Zixuan Zhang et al. Cancer Epidemiology
- A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population
- (2022) David Heredia et al. LUNG CANCER
- Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
- (2021) Sara S. Fois et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer
- (2021) Luiz Henrique Araujo et al. BMC CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project
- (2021) Stephen P. Finn et al. Journal of Thoracic Oncology
- Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations
- (2021) David König et al. Cancers
- P86.18 Prevalence, Clinical Characteristics and Survival of Patients with KRAS Mutant Lung Cancer in Argentina.
- (2021) J. Blaquier et al. Journal of Thoracic Oncology
- P09.24 Real-World Data in Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors in a Latin American Institution
- (2021) T. Paytan et al. Journal of Thoracic Oncology
- P37.04 EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis
- (2021) J. Villena-Vargas et al. Journal of Thoracic Oncology
- A retrospective observational study of the natural history of advanced non–small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease
- (2021) Alexander I. Spira et al. LUNG CANCER
- Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes
- (2021) Thomas John et al. Cancer Epidemiology
- P59.09 Landscape of Targetable Genomic Alterations in Hispanic/Latinx Patients With Non-Small Cell Lung Cancers
- (2021) A. Velazquez et al. Journal of Thoracic Oncology
- Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
- (2021) Barbara Melosky et al. Molecular Diagnosis & Therapy
- p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics
- (2021) Alejandro Ruiz-Patiño et al. Translational Oncology
- Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
- (2021) M. Riudavets et al. ESMO Open
- Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non–Small-Cell Lung Cancer
- (2020) Ana C.Z. Gelatti et al. Clinical Lung Cancer
- The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer
- (2020) Matthew P. Smeltzer et al. Journal of Thoracic Oncology
- Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic
- (2020) Helano C. Freitas et al. Frontiers in Oncology
- Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations
- (2020) Jian Carrot-Zhang et al. Cancer Discovery
- Comprehensive genomic profiling of Brazilian non‐small cell lung cancer patients ( GBOT 0118/ LACOG0418 )
- (2020) Eldsamira Mascarenhas et al. Thoracic Cancer
- Epidemiologic Features of NSCLC Gene Alterations in Hispanic Patients from Puerto Rico
- (2020) Ruifang Zheng et al. Cancers
- NSCLC mutation frequency in the central American and Caribbean region.
- (2019) Luis Corrales-Rodriguez et al. JOURNAL OF CLINICAL ONCOLOGY
- Histopathologic characteristics of advanced-stage ROS1-rearranged non-small cell lung cancers
- (2019) Eunhyang Park et al. PATHOLOGY RESEARCH AND PRACTICE
- OA03.07 Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
- (2019) J. Aredo et al. Journal of Thoracic Oncology
- Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
- (2018) María Verzura et al. Annals of Diagnostic Pathology
- Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
- (2018) Helena A. Yu et al. CLINICAL CANCER RESEARCH
- The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments
- (2018) Luis E. Raez et al. LUNG CANCER
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- EGFR Mutation Testing: Changing Patterns of Molecular Testing in Brazil
- (2018) Sofia Palacio et al. ONCOLOGIST
- Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America
- (2018) Oscar Arrieta et al. ONCOLOGY
- Latin Americans show wide-spread Converso ancestry and imprint of local Native ancestry on physical appearance
- (2018) Juan-Camilo Chacón-Duque et al. Nature Communications
- Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- (2017) Oliver Gautschi et al. JOURNAL OF CLINICAL ONCOLOGY
- P1.02-083 Gene Fusion Profile in Lung Adenocarcinoma Patients in Brazil
- (2017) Tatiane Montella et al. Journal of Thoracic Oncology
- Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients
- (2017) Nicholas T. Gimbrone et al. Journal of Thoracic Oncology
- Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)
- (2017) Andrés F. Cardona et al. Targeted Oncology
- Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations
- (2017) Joshua D. Campbell et al. JAMA Oncology
- RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
- (2016) Shumei Kato et al. CLINICAL CANCER RESEARCH
- PD2.01 (also presented as P1.13): Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar
- (2016) Luis E. Raez et al. Journal of Thoracic Oncology
- The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC
- (2016) Si-Yang Liu et al. Journal of Thoracic Oncology
- Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
- (2016) Alexa B. Schrock et al. Journal of Thoracic Oncology
- Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
- (2015) Conor E. Steuer et al. CANCER
- Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
- (2015) Oscar Arrieta et al. Journal of Thoracic Oncology
- Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil
- (2015) Andreia Cristina de Melo et al. ONCOLOGY
- JBIʼs Systematic Reviews
- (2014) Zachary Munn et al. AMERICAN JOURNAL OF NURSING
- Clinicopathological and Demographical Characteristics of Non-Small Cell Lung Cancer Patients with ALK Rearrangements: A Systematic Review and Meta-Analysis
- (2014) Liang Fan et al. PLoS One
- Lung Adenocarcinoma Biomarker Incidence in Hispanic Versus Non-Hispanic White Patients
- (2013) Elizabeth McQuitty et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- EGFRMutations in US Hispanic Versus Non-Hispanic White Patients With Lung Adenocarcinoma
- (2013) Wei Zhang et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
- (2012) CE Bacchi et al. Clinics
- Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population
- (2012) LF Lopes et al. Clinics
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now